drug
ENS-002
Phase 1updated 3mo agoby Concerto Biosciences Inc
Phase 1community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying ENS-002
News(1)
- Kolon TissueGene cuts 37 US staffers after Phase 3 failFollow along as BioSpace tracks job cuts and restructuring initiatives.biospace · 1d ago
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that